Addressing current challenges with DPIs calls for the development of innovative inhaled formulations. Achieving enhanced formulation efficacy demands the use of advanced technologies and the design of suitable carriers. Furthermore, a key consideration is the development of novel inhalers that actively contribute to minimizing environmental impact.
In this PhD Thesis, aerogels, renowned as the world’s lightest materials due to their high porosity and surface area, along with environmentally friendly approaches, were explored for their potential in pulmonary drug delivery. This research aims to contribute to overcoming existing challenges in DPIs by leveraging the unique properties of aerogels and adopting sustainable practices in pharmaceutical development.